PoliticalRepoPoliticalRepo

Germany · Record · EU-Vorlage

19/30675

Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions EU Strategy on COVID-19 Therapeutics (Dokument liegt nicht in deutscher Sprache vor) KOM(2021) 355 endg.; Ratsdok. 8545/21

Original: Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions EU Strategy on COVID-19 Therapeutics (Dokument liegt nicht in deutscher Sprache vor) KOM(2021) 355 endg.; Ratsdok. 8545/21

Translated from German

openGermany· German Bundestag· DE

Introduced

11 June 2021

Last action

10 December 2021 · Mitteilung des federführenden Ausschusses

Status

open

Sponsors

—

Subjects

Discovery layer

Source updated

2 December 2024

Official sourceShare

Record

Official record 19/30675 from Germany at German Bundestag. Dated 11 June 2021. Status: open.

Timeline

  1. 11 June 2021

    Referral gemäß § 93 Geschäftsordnung BT

    Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions EU Strategy on COVID-19 Therapeutics (Dokument liegt nicht in deutscher Sprache vor) KOM(2021) 355 endg.; Ratsdok. 8545/21

    Source: BT

  2. 10 December 2021

    Mitteilung des federführenden Ausschusses

    Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions EU Strategy on COVID-19 Therapeutics (Dokument liegt nicht in deutscher Sprache vor) KOM(2021) 355 endg.; Ratsdok. 8545/21

    Source: BT

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.